Bristol Myers Squibb Current Ratio 2006-2021 | BMY

Current and historical current ratio for Bristol Myers Squibb (BMY) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bristol Myers Squibb current ratio for the three months ending June 30, 2021 was 1.54.
Bristol Myers Squibb Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $29.16B $18.99B 1.54
2021-03-31 $27.11B $17.33B 1.56
2020-12-31 $30.19B $19.08B 1.58
2020-09-30 $34.28B $20.46B 1.68
2020-06-30 $34.34B $23.42B 1.47
2020-03-31 $31.85B $19.23B 1.66
2019-12-31 $29.35B $18.30B 1.60
2019-09-30 $40.19B $10.49B 3.83
2019-06-30 $37.72B $9.71B 3.88
2019-03-31 $17.09B $8.84B 1.93
2018-12-31 $17.72B $10.65B 1.66
2018-09-30 $14.87B $9.69B 1.53
2018-06-30 $13.87B $9.88B 1.41
2018-03-31 $14.65B $9.62B 1.52
2017-12-31 $14.85B $9.56B 1.55
2017-09-30 $15.05B $9.44B 1.59
2017-06-30 $14.32B $9.02B 1.59
2017-03-31 $13.62B $8.49B 1.60
2016-12-31 $13.70B $8.84B 1.55
2016-09-30 $13.20B $9.00B 1.47
2016-06-30 $12.30B $7.89B 1.56
2016-03-31 $11.22B $7.60B 1.48
2015-12-31 $10.42B $8.02B 1.30
2015-09-30 $12.93B $7.16B 1.81
2015-06-30 $13.06B $7.44B 1.76
2015-03-31 $14.93B $7.69B 1.94
2014-12-31 $14.61B $8.46B 1.73
2014-09-30 $14.18B $8.10B 1.75
2014-06-30 $14.06B $7.80B 1.80
2014-03-31 $14.01B $7.52B 1.86
2013-12-31 $18.92B $12.44B 1.52
2013-09-30 $10.63B $8.28B 1.28
2013-06-30 $10.49B $8.35B 1.26
2013-03-31 $10.08B $8.41B 1.20
2012-12-31 $9.52B $8.28B 1.15
2012-09-30 $9.28B $8.20B 1.13
2012-06-30 $11.01B $6.99B 1.58
2012-03-31 $11.77B $7.21B 1.63
2011-12-31 $15.32B $7.78B 1.97
2011-09-30 $14.87B $7.31B 2.03
2011-06-30 $14.78B $7.41B 1.99
2011-03-31 $13.30B $6.76B 1.97
2010-12-31 $13.27B $6.74B 1.97
2010-09-30 $14.38B $6.28B 2.29
2010-06-30 $12.98B $5.91B 2.20
2010-03-31 $12.53B $6.02B 2.08
2009-12-31 $13.96B $6.31B 2.21
2009-09-30 $13.39B $7.39B 1.81
2009-06-30 $14.57B $6.74B 2.16
2009-03-31 $15.38B $6.63B 2.32
2008-12-31 $14.70B $6.71B 2.19
2008-09-30 $14.78B $6.95B 2.13
2008-06-30 $12.84B $8.64B 1.49
2008-03-31 $10.58B $8.44B 1.25
2007-12-31 $10.10B $8.40B 1.20
2007-09-30 $10.59B $8.05B 1.32
2007-06-30 $11.54B $6.69B 1.73
2007-03-31 $10.56B $6.31B 1.67
2006-12-31 $10.30B $6.50B 1.59
2006-09-30 $11.65B $6.17B 1.89
2006-06-30 $11.80B $5.83B 2.03
2006-03-31 $11.58B $6.00B 1.93
2005-12-31 $12.28B $6.89B 1.78
2005-09-30 $10.15B $6.62B 1.53
2005-06-30 $9.35B $6.63B 1.41
2005-03-31 $12.66B $7.85B 1.61
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $129.416B $42.518B
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Stock Name Country Market Cap PE Ratio
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86